Sciele Pharma has submitted a supplemental new drug application to the FDA for a new formulation of Sular.
Subscribe to our email newsletter
The new formulation utilizes SkyePharma’s patented Geomatrix technology, which has been developed to provide a lower dose of Sular for each of its current doses.
Sular is designed to control high blood pressure.